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    Abstract – An accurate prediction of prognosis to the 
patient diagnosed with Acute Myeloid Leukemia (AML) is 
an enormously difficult task. Several solutions have been 
proposed for prognosis prediction however there is a scope 
to improve current solutions. In this paper we aim at 
developing a solution that estimates the survival time that is 
the Prognosis of patients diagnosed with AML. To that end, 
we used a machine learning model that is built on an 
algorithm called Survival Regression. The model consumes 
as input the Expression Levels of a small number of the 
genes of the patient. 
Keywords - AML, Gene Expression Levels, Machine 
Learning, Prognosis, Survival Regression 
I. INTRODUCTION 
Acute Myeloid Leukemia (AML) is a form of cancer that 
is characterized by infiltration of the bone marrow, blood, and 
other tissues by proliferative, clonal, abnormally 
differentiated, and occasionally poorly differentiated cells of 
the hematopoietic system. Although it was incurable 50 years 
ago, AML is now cured in 35 to 40% of adult patients who are 
60 years of age or younger and in 5 to 15% of patients who 
are older than 60 years of age. The outcome in older patients 
who are unable to receive intensive chemotherapy without 
unacceptable side effects remains dismal, with a median 
survival of only 5 to 10 months [1]. Producing an accurate 
prognosis to the patient diagnosed with AML difficult due to 
its enormous molecular heterogeneity, which means that the 
disease manifests itself with wide diversity on the molecular 
level. However, now with the medical insight provided by the 
genetic profile of the patient, the possibility of acquiring a 
prognosis by studying his genes is promising, especially with 
powerful algorithms that mainly developed within ML field. 
Numerous machine learning algorithms are available. 
However, there is no one size fits all algorithm that can be used 
in developing a model for complex analysis. Typically, the 
algorithms serve specific purposes or specific domain of 
interest. Therefore, to build an analytics model, a modeler 
follows trial-and error principle to discover the best fitting 
algorithm. For instance, a wide number of machine learning 
algorithms and statistical methods have been proposed in a 
large body of literature such as [2] [3] [4] [5] [6] [7]. However, 
the algorithms proposed in these literature produce different 
results and different levels of accuracy. Furthermore, it is 
commonly seen that the existing machine learning algorithms 
very often cannot be used as is, but need to be extended. That 
being said, building a complex analytics model is not a 
straightforward operation; it needs testing various methods 
and algorithms to find best fit in terms of accuracy and 
correctness. 
We studied a number of existing analytics models for 
prognosis. According to our investigation, these models are 
built on the top of different statistical methods and machine 
learning algorithms. The study shows that the accuracy and 
correctness of the results produced by these models vary 
greatly. Also, we strongly believe that the accuracy level 
achieved by the existing solutions is low and can be improved. 
Our objective is to develop and train an efficient machine 
learning model that can estimate the survival time, or the 
prognosis, of a patient diagnosed with AML, with high 
accuracy, using solely the Gene Expression Levels of a small 
group genes. The small number of genes means that the 
testing time and costs will be significantly reduced, as the 
gene expression levels of such number of genes can be 
measured using low-multiplicity technologies. The challenge 
will be to identify from thousands of genes the ones that their 
expression level can be used effectively to give an accurate 
prognosis. And the algorithm that the model will depend on 
is Survival Regression. 
The rest of this paper is organized as follows: the second part 
is a background on some of the concepts needed for the 
understanding of the contribution. The third part is a literary 
view on the subject of machine learning in healthcare. The 
fourth part is our contribution and the fifth is results. The last 
part will be a conclusion. 
II. BACKGROUND 
A. Gene Expression Levels 
Gene Expression is the process by which the information 
from a gene is used in this synthesis of a functional gene 
product such as proteins. Gene expression is context-
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dependent and is regulated in several basic ways: by region, 
dynamic response to environmental elements, by gene 
activity, and in disease states. So it can be said that gene 
expression level is one way of mapping his biological 
functions, and how well his body is being regulated by his 
genes. That is why the amount of gene expression, or the Gene 
Expression Level of the genes of a certain individual can give 
insight into his biological and thus medical profile. 
B. Survival Regression 
Survival analysis is a branch of statistics for analyzing the 
expected duration of time until one or more events happen, 
such as death in biological organisms and failure in 
mechanical system. This is done by studying the relationship 
between the Explanatory Variables that lead to that event in a 
certain group and the Outcome Variable. For example, in 
cancer survival analysis, the event to be observed is the death 
of the patient. The time of survival of the patient is “regressed” 
against the variables that are under study, and the prognosis of 
the patient, or the duration of time before his death, is the 
outcome variable. 
Survival models can be viewed as consisting of two parts: 
the underlying baseline function, often denoted λ0(t), 
describing how the risk of event per time unit changes over 
time at baseline levels of covariates; and the effect 
parameters, describing how the hazard varies in response to 
explanatory covariates [8]. 
One of the branches of survival analysis is the survival 
analysis under the Proportional Hazards Conditions. The 
proportional hazards condition states that covariates are 
multiplicatively related to the hazard. Sir Cox, whom the Cox 
Proportional Hazard Model is attributed to, observed that if 
the proportional hazards assumption holds, then it is possible 
to estimate the effect parameter(s) without any consideration 
of the hazard function. This approach to survival data is called 
application of the Cox proportional hazards model. Cox also 
noted that biological interpretation of the proportional hazards 
assumption can be complicated [8]. 
III. RELATED WORK 
Several works related to prognosis analysis have been 
found in a large bodies of literature. We reported some of the 
notable works related to our research.  
Sara Haddou Bouazza et al. [9] discussed a comparison 
between five feature selection algorithms to extract the most 
significant features from the Gene Microarray Data: F test, T 
test, Signal to noise Ratio (S/R), ReliefF and Pearson Product-
Moment Correlation Coefficient (CC). They used datasets of 
five cancers: Leukemia, Lung, Lymphoma, Central Nervous 
System and Ovarian, and five supervised learning classifiers: 
K Nearest Neighbors (KNN), Support Vector Machines 
(SVMs), Linear Discriminant Analysis (LDA), Decision Tree 
for Classification (DTC), and Naïve Bayes classifier (NB). 
They concluded that the selection methods with highest 
accuracies across classifiers where: S/R, ReliefF, and CC 
respectively.  
Feiyu Xion et al. [10] constructed a machine learning 
framework called KITML (Kernelized Information-Theoretic 
Metric Learning), which depended on the KNN algorithm but 
with improved distance metrics to diagnose cancer by finding 
similar patient biological profiles while dealing efficiently 
with the high dimensionality of microarray gene data. The 
performance of the algorithm was compared to others 
including KNN with Euclidian Metric, SVM, Random Forest 
(RF), and DT. The Macro Average F1 score was used as an 
evaluation metric and it showed higher accuracy of the 
algorithm, with considerable less execution time. 
Sara Tarak et al. [11] classified cancer types by studying 
the Gene Expression Levels in 3 datasets: leukemia, breast, 
and colon using the Matlab Bioinformatics and Statistics 
Toolboxes. They used the KNN algorithm, with K=3 and built 
five classifiers each employing a feature selection method. 
The feature selection methods were chosen to avoid 
redundancy and noise and are: Backward Elimination Hilbert-
Schmidt Independence Criterion (BEHSIC), Extreme Value 
Distribution (EVD) gene selection, and Singular Value 
Decomposition Entropy (SVDEntropy) gene selection. Tuned 
their results using Error Estimation, and evaluated them by 
using Receiver Operating Characteristic (ROC) and Bayesian 
Credible Interval (BRI) methods. 
Kenneth R. Foster et al. [12] published a paper in which 
they discussed the great challenges facing the construction of 
classifiers in the field of bioinformatics, arguing they are 
mostly prone to over-fitting, and generally lack accuracy, and 
face a great challenge in the vast number of parameters that 
can interfere in the diagnosis process that are not taken into 
account. They stated that building classifiers should not be 
views simply as an add-on statistical analysis, but a parcel of 
the experimentation process, and that the validation of the 
classifiers for diagnostic applications should be considered as 
part of a much larger process of establishing the clinical 
validity of the techniques. The article mainly focuses on 
methods to improve the accuracy of SVM classifiers in 
bioinformatics unavoidable. 
Discussion 
The technologies studied in the above tackle the problem of 
prognosis much lesser than diagnosis, as there are many 
solutions proposed on cancer diagnosis using different 
approach like use of medical imaging and Gene Expression 
Levels, however we found little about the prognosis problem. 
To the best of our knowledge, there is no solution proposed to 
tackle the problem of prognosis through the use of Gene 
Expression Levels alone, which have the potential to 
overcome the difficulty of producing accurate models, by 
eliminating much of the diversity in patients and their data, by 
focusing on data from a single, highly reliable source; their 
genetic profiles.  
Furthermore, the implementation of the solutions proposed in 
literature the is done using classical solutions like Matlab and 
other statistical analysis tools rather than using advanced tools 
and technologies. This has limitations from a technical 
standpoint. Firstly, modification of any algorithm extremely 
difficult, very often not possible; the modeler relies on as is 
library provided by the development framework. Hence, 
improvement of a model is a non-trivial task. Optimization of 
performance in terms of computation is entirely impossible. 
Sometimes, technologies of these sorts provide some 
parameters to optimize performance.  
 However, very often it is not an effective approach. 
Specifically, for large-scale datasets, the existing solutions 
cannot be used meaning that the analysis cannot be performed 
these existing solutions. To the best of our  knowledge, the 
scale of the dataset is critical to produce a comprehensive 
result of analysis – which is not possible with existing 
solutions. 
95
IV. PROGMOD – A MODEL FOR PROGNOSIS OF AML PATIENTS 
In this section, we present ProgMod for finding the 
prognosis of AML patients using solely their gene expression 
levels. The process of model construction was sequential and 
iterative (shown in Figure 1), in order to find the model with 
the highest score. The number of features of different models 
varied as the aim was to find an optimal number that is 
preferably below 48. 
A. ProgMod Development Cycle 
The ProgMod development lifecycle consists of four phases:  
Figure 1 - Sequential and Iterative Development Cycle of 
ProgMod 
 
Data Preparation, Feature Selection, Model Construction, 
Model Evaluation. These tasks briefly described in the 
following. 
1) Data Peparation: The dataset we worked with was of 
240 AML patients, and is the combination of 2 datasets. 1) 
GSE 12417 (78 Patients) 2) TCGA (162 Patients). The 
information available about the patinets were three types: 1) 
Social Data (Age and Gender) 2) Clinical Informartion  Data 
(Blast Count, Overall survival time osTime, and overall 
survival status osStatus) 3) Genetic Profile Data (Gene 
Expression Levels). The first step was to clean the data and 
remove the redundant information and extract the ones 
needed i.e. osTime, osStatus, and Gene Expression Levels. 
2) Feature Selection: This was done in two different 
phases: 
a) Preliminary Feature Dimensinonality Reduction: 
The process of applying variance thresholding to remove 
features that have low variance regardless of the value of the 
outcome variable i.e. the overall survival time. This reduced 
the number of featurs from 20000 to 287. 
b) Outcome Reliant Feature Selection: Select from the 
reduced variables the ones that best correlate to the outcome 
variable. Three features selection methods were used and 
tested in order to find the best one, they are: 1) F test 2) 
Recursive Feature Elimination 3) Mutual Info Selection. 
Sklearn’s feature selection module can be used for feature 
selection/dimensionality reduction on sample sets, either to 
improve estimators’ accuracy scores or to boost their 
performance on very high-dimensional dataset 
All the features that had a very low variance in 80% of the 
patients were dropped. The result of this process was to 
                                                        
1 http://facweb.cs.depaul.edu/sjost/csc423/documents/f-test-reg.htm 
2 https://medium.com/@aneesha/recursive-feature-elimination-with-scikit-
learn-3a2cbdf23fb7 
reduce the number of features from about 20,000 to 287, these 
are the ones that will be used in the next step. 
The second step is outcome reliant feature selection i.e. 
selecting the features that best correlate to the outcome 
variable, the survival time. First, and since the two dataset 
have different methods of measurements of Gene Expression 
Levels, they could not be used merged together to perform 
feature selection. Instead, the larger dataset, TCGA, 
containing 178 patients, was used as a features selection set, 
and the second dataset was used as a testing set.  
Three feature selection methods were tried, evaluated, and the 
one that had the best results was eventually used in the final 
model. The three feature selection methods are all modules in 
sklearn’s feature selection module. They are the modules: 
- f_regresion: the f_test for regression tests whether 
any of the independent variables in a multiple linear 
regression model is significant using the ratio of 
variances obtained from the means squared value. 1 
- rfe_regression: recursive feature elimination 
recursively removes features, builds a model using 
the remaining attributes and calculates model 
accuracy. RFE is able to work out the combination 
of attributes that contribute to the prediction on the 
target variable.2 
- Mutual_info_regression: Mutual information is a 
measure between two (possibly multi-dimensional) 
random variables XX and YY that quantifies the 
amount of information obtained about one random 
variable, through the other random variable. 3 
The pseudo-code for the algorithm used to select the best 
model was the following: 
 
for num_features in range (10, 48): 
features = select_features 
(num_features, Feature_Selection_Set) 
model_score = evaluate_model 
(features, Test_Set_1, Test_Set_2) 
 
3) Model Constrction: Cox Proportional Hazard 
Regression Model is used for developing analytics model. It 
is probably the most popular regression technique for 
regression analysis of survival data [8]. The power of the Cox 
Model, and what distinguishes it from linear or logistic 
regression, is its ability to account for censored data points, 
i.e. data points that the time of event remains unknown. In our 
example, if the patient that did not die at the end of the 
standard five year follow up period, his overall survival status 
is labeled as “censored event”. The Cox Model does not 
assume the hazard value to be constant, but rather a function 
of time. This is due to the fact the hazard in Cox Model is the 
same as the incidence rate i.e. the ratio of the subjects who 
died over the overall number of subjects ((number of death 
events)/(total number of patinets)), thus as time passes and 
subjects die, the incidence rate, or the hazard, varies. This 
keeps the Model in continuous variation, with the incidence 
rate and model predictions variating as data points are 
3 https://thuijskens.github.io/2017/10/07/feature-selection/ 
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modified or added to it.  If  Xi = {X1, X2 … Xn} are the values 
of the covariates of subject i, the equation for the Cox Model: 
 ln 𝑖𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 = 	𝛽+ + ∑	𝛽.	(𝑋.) 
 
This equation produces a survival function for each patient, 
showing the probability of survival over a period of time 
(Figure 2).  
4) Model Evaluation: As mentioned the Cox Model 
predicts a survival function of the probability of the event of  
Figure 2 - Patient Survival Function 
 
death over time. While this result is ultimately desired, it is 
difficult to evaluate the accuracy of the model when the real 
value is a number and the predicted value is a function. So an 
algorithm was improvised. 
Each model was evaluated by fitting the data with the 
features resulting from the features selection process in to the 
testing set and scoring the model. The score of each model 
was acquired using the module r2_squard_accuracy in 
sklearn’s module: metrics. R2 Squared Accuracy is an 
algorithm used to predict how well the model will perform on 
future unseen data. It takes two matrices, one with the real 
values and one with the predicted values. 
The real values used were the actual survival months of 
the patients. The predicted values were the values in the 
survival function corresponding to constant probability value. 
The probability value is irrelevant in this case because the 
purpose is comparison between different models. The 
predicted survival value for each patient was the value 
corresponding to 0.8 probabilty in the survival function. 
B. Implementation of ProgMod  
ProgMod was implemented using different Python-based, 
open-source libraries available to perform data acquisition 
and transformation (Pandas and Numpy), analysis (Scikit 
Learn), and visualization (PyPlot). 
For the implementation of the Cox Proportional Hazard 
Model, we used the open-source library lifelines, downloaded 
from the lifelines website4, and performed some tweaking 
and a wrapper around its functions to suit the needs of my 
implementation. Lifelines is a library that implements 
survival analysis models, including the Cox Proportional 
Hazard Model. 
                                                        
4https://lifelines.com  
V. EXPERIMENTS AND RESULTS 
In this section, we reported results of experiments that we 
conducted to evaluate ProgMod. I discussed how my model 
produced results, more specifically prognosis prediction. 
A. Model Fitting with Test Data 
Using the test set, the gene expression levels of the 47 
genes selected in the previous step were fitted in the Cox 
Model alongside the overall survival time and the survival 
status. The model was the used to predict the survival 
function the patients. 
For the purpose of scoring the model the value from the 
survival function of each patient corresponding to the fixed 
probabilty 0f 0.8 was taken, and was considered the predicted 
survival time for that patient. Then the array of real values 
and predicted values were used to score and visualize the 
result of the model. 
B. Model Scoring 
Two metrics were used to score the model in each test 
set, both in sklearn’s module: metrics: 
- R2 Squared Accuracy: used to predict how well the 
model will perform on future unseen data. Its 
formula is:	1 − 45∑ (6.768.)95:;445∑ (6.76<<.)95:;4    where Yi is the real 
value, Y’i is the predicted value, and Y’’i is the mean 
value. 
- Root Mean Squared Error: used to calculate the 
average error per data point. Its formula is:   =>?∑ (𝑦𝑗 − 𝑦<𝑗)B?CD>    where yj and y’j are the real 
and predicted values.  
Finally, the lifeline implementation of the Cox Model has its 
own score. When data is fitted into the model, it provides a 
summery containing a score called the concordance score, 
and it show how well the data fit the model. 
C. Model Results & Evaluation 
For the test set GSE12417, we plotted the Real and 
predicted values to visualize which is shown in Figure 3. 
 
 
Figure 3 - Plot of Real and Predicted Values 
 
Table I shows the model score by different metrics. 
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TABLE I Model Score  
 
Metric R2 Squared  RMSE 
Score 0.75 9 
 
We tested the Cox model. Table II shows the results of 
the Cox model. 
 
TABLE II Summary of experiments with Cox Model 
  
Gene Coef  exp(c
oef) 
se(co
ef) 
Z P Lower
_0.95 
Upp
er_0
.95 
14107 
-
2.39
19 
0.091
5 
1.537
3 
-
1.555
9 
0.119
7 -5.405 
0.62
11 
19804 0.1528 
1.165
1 0.533 
0.286
7 
0.774
3 
-
0.891
8 
1.19
74 
19804 0.1528 
1.165
1 0.533 
0.286
7 
0.774
3 
-
0.891
8 
1.19
74 
2663 0.9846 
2.676
8 
0.692
1 
1.422
6 
0.154
9 -0.372 
2.34
12 
5250 
-
1.45
43 
0.233
6 
0.936
5 -1.553 
0.120
4 
-
3.289
8 
0.38
12 
11694 0.3508 
1.420
2 
0.643
1 
0.545
4 
0.585
5 
-
0.909
7 
1.61
13 
9597 0.1556 
1.168
4 
0.384
8 
0.404
3 0.686 
-
0.598
7 
0.90
99 
18177 0.5393 
1.714
8 
0.262
7 
2.052
6 
0.040
1 
0.024
3 
1.05
43 
18585 0.1553 1.168 
0.492
8 
0.315
1 
0.752
7 
-
0.810
6 
1.12
11 
6655 
-
0.66
85 
0.512
5 
0.700
3 
-
0.954
6 
0.339
8 
-
2.041
1 
0.70
41 
8213 
-
0.68
22 
0.505
5 
0.648
4 
-
1.052
3 
0.292
7 -1.953 
0.58
85 
3048 
-
0.63
01 
0.532
6 
0.358
3 
-
1.758
3 
0.078
7 
-
1.332
4 
0.07
22 
1419 0.0886 
1.092
6 
0.331
5 
0.267
1 
0.789
4 
-
0.561
2 
0.73
83 
12264 0.733 
2.081
3 
0.875
7 0.837 
0.402
6 
-
0.983
4 
2.44
94 
19282 
-
3.33
36 
0.035
7 1.058 -3.151 
0.001
6 
-
5.407
2 
-
1.26
01 
11120 
-
0.30
26 
0.738
9 
0.663
9 
-
0.455
9 
0.648
5 
-
1.603
8 
0.99
85 
15456 0.4814 
1.618
3 
0.269
1 
1.788
9 
0.073
6 -0.046 
1.00
88 
9945 0.559 1.749 
0.510
5 1.095 
0.273
5 
-
0.441
6 
1.55
96 
11893 1.2217 
3.393
1 
0.464
9 
2.628
1 
0.008
6 
0.310
6 
2.13
29 
5604 2.0518 
7.781
7 
0.524
5 
3.911
5 
0.000
1 
1.023
7 
3.07
99 
9279 
-
0.56
72 
0.567
1 
0.542
1 
-
1.0462 
0.29
55 
-
1.629
7 
0.49
54 
19432 
-
1.39
56 
0.247
7 
0.314
6 
-
4.4364 0 
-
2.012
2 
-
0.77
9 
3910 1.9807 
7.247
9 0.798 2.482 
0.01
31 
0.416
6 
3.54
48 
8240 
-
1.77
41 
0.169
6 
0.556
6 
-
3.1871 
0.00
14 
-
2.865
1 
-
0.68
31 
15024 1.7129 5.545 
0.410
3 4.1751 0 
0.908
8 
2.51
7 
8704 
-
1.65
38 
0.191
3 
0.485
8 
-
3.4044 
0.00
07 
-
2.605
9 
-
0.70
17 
2449 0.072 
1.074
7 1.022 0.0705 
0.94
38 
-
1.931
1 
2.07
51 
6773 
-
0.15
85 
0.853
4 
0.458
4 
-
0.3457 
0.72
96 -1.057 0.74 
11050 
-
1.11
74 
0.327
1 
0.401
8 -2.781 
0.00
54 
-
1.904
8 
-
0.32
99 
3675 0.7704 
2.160
6 
0.359
1 2.1451 
0.03
19 
0.066
5 
1.47
43 
4025 1.475 
4.371
2 
0.774
3 1.9049 
0.05
68 
-
0.042
6 
2.99
27 
5510 -1.01 
0.364
2 
0.652
8 -1.547 
0.12
19 
-
2.289
5 
0.26
96 
4780 0.3181 
1.374
5 
0.364
7 0.872 
0.38
32 
-
0.396
8 
1.03
29 
1420 1.055 
2.872
1 
0.377
5 2.7946 
0.00
52 
0.315
1 
1.79
5 
59 0.1503 
1.162
1 
0.362
9 0.4141 
0.67
88 -0.561 
0.86
15 
5521 1.9321 
6.904
2 
0.517
4 3.7345 
0.00
02 
0.918
1 
2.94
62 
6772 0.9128 
2.491
3 0.366 2.494 
0.01
26 
0.195
5 
1.63
02 
4181 1.5159 
4.553
7 
0.548
8 2.7624 
0.00
57 
0.440
4 
2.59
15 
18134 
-
1.05
03 
0.349
8 
0.477
9 
-
2.1977 
0.02
8 -1.987 
-
0.11
36 
6552 0.315 
1.370
2 
0.625
4 0.5037 
0.61
45 
-
0.910
7 
1.54
07 
7596 1.0771 
2.936
2 0.308 3.4974 
0.00
05 
0.473
5 
1.68
07 
18504 0.4695 
1.599
2 0.475 0.9885 
0.32
29 
-
0.461
4 
1.40
05 
3039 
-
0.23
58 
0.79 0.2144 
-
1.0997 
0.27
15 
-
0.655
9 
0.18
44 
445 
-
3.94
46 
0.019
4 
1.050
7 
-
3.7541 
0.00
02 -6.004 
-
1.88
52 
6764 0.1693 
1.184
5 
0.807
3 0.2097 
0.83
39 -1.413 
1.75
16 
4550 
-
1.02
98 
0.357
1 
0.318
9 
-
3.2294 
0.00
12 
-
1.654
9 
-
0.40
48 
17847 0.5091 
1.663
8 
0.157
3 3.2372 
0.00
12 
0.200
9 
0.81
73 
98
3677 
-
0.55
96 
0.571
4 
0.372
1 -1.504 
0.13
26 
-
1.288
9 
0.16
97 
 
The interpretation of the summary is the following: 
- Statistical Significance: The column marked “z” 
gives the Wald statistic value. It corresponds to the 
ratio of each regression coefficient to its standard 
error (z = coef/se (coef)). The Wald statistic 
evaluates, whether the beta (β) coefficient of a given 
variable is statistically significantly different from 0. 
- The Regression Coefficients: The second feature to 
note in the Cox model results is the sign of the 
regression coefficients (coef). A positive sign means 
that the hazard (risk of death) is higher, and thus the 
prognosis worse, for subjects with higher values of 
that variable. 
- Hazard Ratios: The exponentiated coefficients (exp 
(coef) = exp (-0.53) = 0.59), also known as hazard 
ratios, give the exact size of covariates. 
- Confidence Intervals of the Hazard Ratios. The 
summary output also gives upper and lower 95% 
confidence intervals for the hazard ratio (exp 
(coef)).  
For Example, the genes 5604, 19432, 5521, 7596, and 445 
have a p value < 0.001 and are the ones with the most 
statistical significance. These means that although we need 
all 47 genes to predict an accurate prognosis, these 5 genes 
are pretty good indicators of the prognosis of the patient. 
 
VI. CONCLUSION AND FUTURE WORKS 
In recent years, Bioinformatics is adopting mainstream 
technologies of computer science in performing various 
complex tasks. Machine learning – a branch of computer 
science- is one of the most popular fields of development of 
analytical models for performing analysis on critical, 
lifesaving subjects such as acute myeloid leukemia (AML). 
However, since there is an exhaustive number of algorithms 
and methods offered by ML, it is non-trivial task to find the 
best one without experimenting them. Furthermore, different 
models developed using different approaches produce 
different results with different accuracy levels.  
We investigated different models proposed in literature for 
prognosis to the patients diagnosed with AML. According to 
our study, the results of these models vary which essentially 
imply that there is a possibility that the existing models could 
be improved in terms of accuracy. 
In this paper, we presented a model to estimate the 
prognosis of AML patients using the Cox Proportional Hazard 
Model for survival analysis, using their Gene Expression 
Levels solely as the explanatory variables, thus overcoming 
the issue of high molecular heterogeneity of AML when it 
comes to prognosis prediction. 
We have shown that it can estimate the survival time with 
r2_squared accuracy of 0.75 with the used dataset. And the 
model is valid to perform prediction on future patients. The 
number of genes that the model was constructed to work with 
is 47, a small number that with modern technologies can be 
tested with relatively small costs and time. 
An extension of this work is lined up. That is, this 
approach can be extended to all sorts of cancer. However, the 
model has to be adjusted and generalized to select the 
significant genes, and perform the prognosis prediction of any 
cancer, based on the Gene Expression Levels of these selected 
genes. 
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